![Erik Esveld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Esveld
Direttore Finanziario/CFO presso
Van Herk Investments BV
Profilo
Erik Esveld currently works at Van Herk Groep BV, as Finance Director, Van Herk Investments BV, as Chief Financial Officer from 2012, Agendia NV, as Member-Supervisory Board from 2016, Agendia, Inc., as Member-Supervisory Board, and SkylineDx BV, as Member-Supervisory Board.
Mr. Esveld also formerly worked at Mendus AB, as Director, AEC Skyline Holding BV, as Director, Stichting Op Klompen Begonnen, as Director, Stichting Start2Cure, as Director, de Hoben GmbH, as Director, Campus Fraxinus Excelsior BV, as Director, Ht Projecktentwicklung GmbH, as Director, and BioInvent International AB, as Independent Director.
Mr. Esveld received his graduate degree in 2020 from Nyenrode Business Universiteit and undergraduate degree in 1994 from Erasmus University Rotterdam.
Posizioni attive di Erik Esveld
| Società | Posizione | Inizio |
|---|---|---|
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments invests in companies located in Central and Eastern Europe, India and the United States, primarily in Europe with an enterprise value ranging from EUR 10 - 150 million. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. It also makes investments public companies and venture capital funds. | Direttore Finanziario/CFO | 20/12/2005 |
Van Herk Groep BV
 Van Herk Groep BV HomebuildingConsumer Durables Provides construction services for residential and utility buildings, healthcare & education sectors | Direttore Finanziario/CFO | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Direttore/Membro del Consiglio | 01/02/2016 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Direttore/Membro del Consiglio | - |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services Develops molecular diagnostic tests for blood cancers | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Erik Esveld
| Società | Posizione | Fine |
|---|---|---|
Ht Projecktentwicklung GmbH | Direttore/Membro del Consiglio | - |
Campus Fraxinus Excelsior BV | Direttore/Membro del Consiglio | - |
de Hoben GmbH
 de Hoben GmbH Real Estate DevelopmentFinance Engages in buying and selling of land, buildings and apartments | Direttore/Membro del Consiglio | - |
Stichting Op Klompen Begonnen
 Stichting Op Klompen Begonnen Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direttore/Membro del Consiglio | - |
| ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Erik Esveld
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments invests in companies located in Central and Eastern Europe, India and the United States, primarily in Europe with an enterprise value ranging from EUR 10 - 150 million. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. It also makes investments public companies and venture capital funds. | Finance |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Van Herk Groep BV
Van Herk Groep BV HomebuildingConsumer Durables Provides construction services for residential and utility buildings, healthcare & education sectors | Consumer Durables |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services Develops molecular diagnostic tests for blood cancers | Health Services |
AEC Skyline Holding BV | |
Stichting Op Klompen Begonnen
Stichting Op Klompen Begonnen Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Stichting Start2Cure
 Stichting Start2Cure Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
de Hoben GmbH
de Hoben GmbH Real Estate DevelopmentFinance Engages in buying and selling of land, buildings and apartments | Finance |
Campus Fraxinus Excelsior BV | |
Ht Projecktentwicklung GmbH |
